StonvexLoading…
StonvexStonvexStonvexCore line items from RIME's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-03-31 |
|---|---|---|---|---|
Revenue | $4.39M | $297.00K | $29.20M | $39.30M |
Operating Income | $-7.95M | $-8.44M | $-6.14M | $-3.70M |
Net Income | $-15.87M | $-23.26M | $-6.40M | $-4.64M |
EPS (Diluted) | $-6.41 | $-353.87 | $-263.04 | $-1.65 |
Total Assets | $12.72M | $18.30M | $27.71M | $16.65M |
Total Liabilities | $14.58M | $28.82M | $20.14M | $6.32M |
Cash & Equivalents | $1.63M | $7.23M | $6.70M | $2.90M |
Free Cash Flow OCF − CapEx | $-7.32M | $-8.63M | $343.00K | $-574.00K |
Shares Outstanding | 3.41M | 470.82K | 32.09K | 3.17M |